Expansion, Differentiation, and Validation of Neural Progenitor Cells (NPCs) from Human Induced Pluripotent Stem Cells (iPSCs) Derived from Psychiatrically Revelent Subjects.
Award Notice Posted
- Solicitation number
- NIMH-20-003939
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Awarded
- to New York Stem Cell Foundation Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N95020C00034 Federal contract award
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- Q301 Reference Laboratory Testing
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute on Drug Abuse awarded a $414,000 contract to the New York Stem Cell Foundation, Inc. on September 26, 2020. The contract is for the expansion, differentiation, and validation of neural progenitor cells derived from human induced pluripotent stem cells obtained from psychiatrically relevant subjects. The goal is to further the development of stem cell-based models and platforms that can be utilized to study substance use disorders and evaluate potential pharmacotherapies.
Notice text
Awarded contract 75N95020C00034 to NEW YORK STEM CELL FOUNDATION, INC. for 414000.00 on 2020-09-28.
Notice history
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity